A recent study published in the journal of Eye journal revealed a significant reciprocal link between atrial fibrillation (AF) and age-related macular degeneration (AMD) in the elderly.
CLEVELAND, Ohio — People who are of European descent may be more at risk of age-related macular degeneration than those of African or Hispanic ancestry, suggests a new study from Case Western Reserve ...
1don MSN
Reducing inflammation may protect against early age-related macular degeneration-like vision loss
University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...
Apellis Pharmaceuticals recently announced post hoc analysis data of the GALE extension study. This new data is the result of ...
SAN FRANCISCO — A large European study released Tuesday found that daily aspirin use is linked to an increased risk of age-related macular degeneration, a disease that can damage the central vision ...
Techno-Science.net on MSN
👁️ A subretinal implant partially restores vision in people with AMD
Age-related macular degeneration (AMD) causes progressive vision loss in a large number of elderly people, and no treatment ...
In a first-in-human phase 1/2a clinical trial, researchers used adult stem cells to help restore vision in people with age-related macular degeneration. In the United States, age-related macular degen ...
Study reveals link between socioeconomic inequality and the risk of age-related macular degeneration
A recent study conducted by researchers from Shanghai Jiao Tong University School of Medicine and Fudan University has revealed a significant association between socioeconomic status (SES) inequality ...
GLP-1 drugs are associated with a higher risk of “wet” age-related macular degeneration in people with type 2 diabetes, according to a new study. Researchers found that the risk substantially ...
The overall dry AMD market size in the US is anticipated to increase, due to the uptake of recently approved therapies, the launch of emerging therapies such as Gildeuretinol (Alkeus Pharmaceuticals), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results